Cambridge-based anti-obesity drug developer Zafgen Inc bagged another USD45 million in a Series E funding round today, bringing its total funding to date to USD114 million.
Alta Partners
Breaking News
aTyr Pharma reveals that it had secured up to US$59 million in financing from current investors and an anonymous global public investment fund.
Subscribe to VCpost newsletter
Most Popular
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Tesla Spends $200,000 in Promoting Elon Musk's Social Media Platform X Following Mention of 'Minimal Advertising Efforts'
- Australian Farmer Prepares Grave of 3,000 Sheep After Failing to Find Buyer
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Brazilian Woman Wheels Her Dead Uncle Into the Bank to Withdraw Loan in His Name
- Elon Musk's SpaceX Working With Northrop Grumman on Secret Spy Satellite Project for US Intelligence: Report
- Michigan Family Sues Wendy's for $20 Million After 11-Year-Old Girl Suffered Deadly E.Coli Infection
- Innocent Female Uber Driver, 61, Shot Dead by 81-Year-Old Ohio Man Who Was Targeted by Scammers
